9. Korpi, E. R., and H. Lu ̈ ddens. Regional g-aminobutyric acid sensitivity of
t-butylbicyclophosphoro[35S]thionate binding depends on g-aminobutyric
acidA receptor α subunit. Mol. Pharmacol. 44:87–92 (1993). 26.
10. Korpi, E. R., T. Kuner, P. H. Seeburg, and H. Lu ̈ ddens. Selective antagonist for the cerebellar granule cell-specific g-aminobutyric acid type A
receptor. Mol. Pharmacol. 47:283–289 (1995). 27.
11. Nusser, Z., W. Sieghart, F. A. Stephenson, and P. Somogyi. The α6 subunit
of the GABAA receptor is concentrated in both inhibitory and excitatory
synapses on cerebellar granule cells. J. Neurosci. 16:103–114 (1996). 28.
12. Zhu, W. J., J. F. Wang, S. Vicini, and D. R. Grayson. α6 and g2 subunit
antisense oligodeoxynucleotides alter g-aminobutyric acid receptor pharmacology in cerebellar neurons. Mol. Pharmacol. 50:23–33 (1996). 29.
13. Zhu, W. J., J. F. Wang, K. E. Krueger, and S. Vicini. d Subunit inhibits
neurosteroid modulation of GABAA receptors. J. Neurosci. 16:6648–6656
(1996). 30.
14. Jones, A., E. R. Korpi, R. M. McKernan, R. Pelz, Z. Nusser, R. Ma ̈ kela ̈ , J. R.
Mellor, S. Pollard, S. Bahn, F. A. Stephenson, A. D. Randall, W. Sieghart,
P. Somogyi, A. J. H. Smith, and W. Wisden. Ligand-gated ion channel
subunit partnerships: GABAA receptor α6 subunit gene inactivation in- 31.
hibits d subunit expression. J. Neurosci. 17:1350–1362 (1997).
15. Homanics, G. E., C. Ferguson, J. J. Quinlan, J. Daggett, K. Snyder, C.
Lagenaur, Z.-P. Mi, X.-H. Wang, D. R. Grayson, and L. L. Firestone. Gene
knockout of the α6 subunit of the g-aminobutyric acid type A receptor: lack 32.
of effect on responses to ethanol, pentobarbital, and general anesthetics.
Mol. Pharmacol. 51:588–596 (1997).
16. Turner, D. M., D. W. Sapp, and R. W. Olsen. The benzodiazepine/alcohol 33.
antagonist Ro-15–4513: binding to a GABAA receptor subtype that is
insensitive to diazepam. J. Pharmacol. Exp. Ther. 257:1236–1242 (1991).
17. Bahn, S., R. J. Harvey, M. G. Darlison, and Wisden W. Conservation of 34.
g-aminobutyric acid type A receptor α6 subunit gene expression in cerebellar granule cells. J. Neurochem. 66:1810–1818 (1996).
18. Hadingham, K. L., E. M. Garrett, K. A. Wafford, C. Bain, R. P. Heavens,
D. J. S. Sirinathsinghji, and PJ. Whiting. Cloning of cDNAs encoding the 35.
human g-aminobutyric acid type A receptor α6 subunit and characterization of the pharmacology of α6-containing receptors. Mol. Pharmacol.
49:253–259. (1996).
19. Korpi, E. R., P. H. Seeburg, and H. Lu ̈ ddens. Modulation of GABAA 36.
receptor tert-[35S]butylbicyclophosphorothionate binding by antagonists:
relationship to patterns of subunit expression. J. Neurochem. 66:2179–
2187 (1996). 37.
20. Olsen, R. W., R. T. McCabe, and J. K. Wamsley. GABAA receptor subtypes:
autoradiographic comparison of GABA, benzodiazepine, and convulsant
binding sites in the rat central nervous system. J. Chem. Neuroanat. 38.
3:59–76 (1990).
21. Wong, G., M. Sarviharju, M. Toropainen, D. Matecka, and E. R. Korpi.
Pharmacologic actions of subtype-selective and novel GABAergic ligands
in rat lines with differential sensitivity to ethanol. Pharmacol. Biochem. 39.
Behav. 53:723–730 (1996).
22. Luque, J. M., R. Erat, R. Kettler, A. Cesura, M. Da Prada, and J. G.
Richards. Radioautographic evidence that the GABAA receptor antagonist 40.
SR 95531 is a substrate inhibitor of MAO-A in the rat and human locus
coeruleus. Eur. J. Neurosci. 6:1038–1049 (1994).
Lu ̈ ddens, H., and W. Wisden. Function and pharmacology of multiple
GABAA receptor subunits. Trends Pharmacol. Sci. 12:49–51 (1991).
Olsen, R. W. Drug interactions at the GABA receptor-ionophore complex.
Annu. Rev. Pharmacol. Toxicol. 22:245–277 (1982).
Heaulme, M., J.-P. Chambon, R. Leyris, J.-C. Molimard, C. G. Wermuth,
and K. Biziere. Biochemical characterization of the interaction of three
